 Joshua J Lingo
| Title | Post-Doctoral Fellow |
|---|
| Institution | University of Colorado Denver - Anschutz Medical Campus |
|---|
| Department | SOM-DERM General Operations |
|---|
|
|
|
 Bibliographic
-
Lingo JJ, Reis R, Allamargot C, Raygoza Garay JA, Kaemmer CA, Elias EC, Voigt E, Jabbari A, Wilhelm CR, Boyden AW, Karandikar NJ, Breheny P, Meyerholz DK, Dodd RD, Houtman JCD, Darbro BW, Quelle DE. Intratumoral plasma cells mediate CD8+ T cell infiltration and successful immune checkpoint blockade therapy in de novo MPNSTs. bioRxiv. 2026 Feb 20. PMID: 41756924.
-
Lingo JJ, Balas MM, Bashyam AM, Hosler GA, Squiers GT, Klein JC. Proteomics and single-cell transcriptomics identify LRP1 as a diagnostic biomarker for atypical fibroxanthoma and pleomorphic dermal sarcoma. bioRxiv. 2026 Feb 09. PMID: 41727100.
-
Lingo JJ, Balas MM, Scherer PE, Klein JC. The Role of COL6A3 in Tumorigenesis, Metastasis, Diagnosis, and Disease Management. Cancers (Basel). 2025 Oct 28; 17(21). PMID: 41228242.
-
Lingo JJ, Elias EC, Quelle DE. Novel Therapeutics and the Path Toward Effective Immunotherapy in Malignant Peripheral Nerve Sheath Tumors. Cancers (Basel). 2025 Jul 21; 17(14). PMID: 40723291.
-
Lingo JJ, Voigt E, Quelle DE. Linking FOXM1 and PD-L1 to CDK4/6-MEK targeted therapy resistance in malignant peripheral nerve sheath tumors. Oncotarget. 2024 Sep 30; 15:638-643. PMID: 39347707.
-
Natarajan P, Horak K, Rowe J, Yoon S, Lingo J, Tomich JM, Fleming SD. Biodistribution Analysis of Peptide-Coated Magnetic Iron Nanoparticles: A Simple and Quantitative Method. Mol Pharm. 2024 Feb 05; 21(2):970-981. PMID: 38206824.
-
Natarajan P, Horak K, Rowe J, Lingo J, Tomich JM, Fleming SD. Biodistribution Analysis of Peptide-Coated Magnetic Iron Nanoparticles: A Simple and Quantitative Method. bioRxiv. 2023 Oct 11. PMID: 37873129.
-
Kohlmeyer JL, Lingo JJ, Kaemmer CA, Scherer A, Warrier A, Voigt E, Raygoza Garay JA, McGivney GR, Brockman QR, Tang A, Calizo A, Pollard K, Zhang X, Hirbe AC, Pratilas CA, Leidinger M, Breheny P, Chimenti MS, Sieren JC, Monga V, Tanas MR, Meyerholz DK, Darbro BW, Dodd RD, Quelle DE. CDK4/6-MEK Inhibition in MPNSTs Causes Plasma Cell Infiltration, Sensitization to PD-L1 Blockade, and Tumor Regression. Clin Cancer Res. 2023 09 01; 29(17):3484-3497. PMID: 37410426.
-
Kohlmeyer JL, Kaemmer CA, Lingo JJ, Voigt E, Leidinger MR, McGivney GR, Scherer A, Koppenhafer SL, Gordon DJ, Breheny P, Meyerholz DK, Tanas MR, Dodd RD, Quelle DE. Oncogenic RABL6A promotes NF1-associated MPNST progression in vivo. Neurooncol Adv. 2022 Jan-Dec; 4(1):vdac047. PMID: 35571990.
-
Girardi G, Lingo JJ, Fleming SD, Regal JF. Essential Role of Complement in Pregnancy: From Implantation to Parturition and Beyond. Front Immunol. 2020; 11:1681. PMID: 32849586.
-
Szmania S, Lapteva N, Garg T, Greenway A, Lingo J, Nair B, Stone K, Woods E, Khan J, Stivers J, Panozzo S, Campana D, Bellamy WT, Robbins M, Epstein J, Yaccoby S, Waheed S, Gee A, Cottler-Fox M, Rooney C, Barlogie B, van Rhee F. Ex vivo-expanded natural killer cells demonstrate robust proliferation in vivo in high-risk relapsed multiple myeloma patients. J Immunother. 2015 Jan; 38(1):24-36. PMID: 25415285.
This graph shows the total number of publications by year, by first, middle/unknown, or last author.
To see the data from this visualization as text, click here.
| Year | Publications |
|---|
| 2015 | 1 | | 2020 | 1 | | 2022 | 1 | | 2023 | 2 | | 2024 | 2 | | 2025 | 2 | | 2026 | 2 |
To return to the timeline, click here.
|
Lingo's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|